NCT06654206Toborzás még nem indultKorai 1. fázis
Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia Patients
Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia Patients on Quality of Life, Mental Health, and Frailty.
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2025. febr. 19. · Több mint 12 hónapja nem frissült - kérdezd meg a helyszínt, nyitott-e még
Rövid összefoglaló (regiszter, angolul)
Chronic lymphocytic leukemia (CLL) is a hematological neoplasm that primarily affects older individuals and is the most common type of leukemia in adults in Western countries. CLL mainly affects older adults, with an average age at diagnosis of around 70 years, and there is a slightly higher risk in men compared to women. It is characterized by the proliferation of clonal B lymphocytes in peripheral blood, bone marrow, and lymphoid organs. Although CLL has a relatively slow progression in many cases, patients may experience chronic fatigue, muscle weakness, functional impairment, and psychological disorders, such as anxiety and depression, which significantly affect their quality of life. In this context, it has been shown that physical exercise, especially strength training, can considerably improve physical and psychological conditions in oncology populations, such as those with breast cancer and colorectal cancer, as well as in older adults, where the benefits of resistance training are widely recognized. These benefits include increased muscle strength, reduced fatigue, improved functional abilities, psychological well-being, and overall quality of life. Furthermore, there is evidence that exercise can reduce systemic inflammatory markers, such as C-reactive protein (CRP), and improve lipid profiles by lowering total cholesterol and triglycerides, which is crucial for cancer patients at risk of cardiovascular diseases.
- Állapot (regiszter)
- Toborzás még nem indult
- Fázis (regiszter)
- Korai 1. fázis
- Vizsgálattípus
- Beavatkozással járó
- Résztvevők száma
- 40 (tervezett)
- Első benyújtás
- 2024. okt. 21.
- Kezdés
- 2025. márc. 10.
- Elsődleges befejezés
- 2025. dec. 31.
- Fő szponzor
- University of Salamanca
- NCT-szám
- NCT06654206
Mit vállalsz
- Vizsgálat típusa: Beavatkozással járó · Korai 1. fázis
- Tervezett résztvevők: 40
- 2025. márc. 10. és az elsődleges befejezés (2025. dec. 31.) között
- Nincs megadott helyszín, ország nélkül
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Más betegség
- The presence of any medical contraindications to physical exercise, such as severe musculoskeletal disorders, serious cardiovascular diseases, bone metastases, or other conditions as determined by a healthcare professional.
Egyéb
- Participants unable to complete the initial evaluation tests or who have difficulty performing basic exercises.
- Other circumstances, as determined by the researchers, that may interfere with the study's objectives or development.
- Participants will be discontinued if they meet any of the following:
- Negative developments or progression of the tumor process.
- Severe adverse events related to exercise.
- Voluntary withdrawal from the intervention.
- New medical contraindications that prevent safe participation.
- Non-adherence to the intervention protocol that compromises study integrity.
Kiket keres a vizsgálat
- Participants diagnosed with CLL or Small Lymphocytic Lymphoma (SLL) undergoing active treatment.
- Participants who have not engaged in regular physical activity in the past 8 weeks.
- Performance Status (ECOG) 0-1.
- Signed informed consent.
Nem: nők és férfiak · Egészséges önkénteseket nem fogad
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.